Calithera Biosciences Buy Hold or Sell Recommendation

CALADelisted Stock  USD 0.05  0.00  0.00%   
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Calithera Biosciences is 'Not Rated'. Macroaxis provides Calithera Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CALA positions.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
In addition, we conduct extensive research on individual companies such as Calithera and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Calithera Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Calithera Biosciences Buy or Sell Advice

The Calithera recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Calithera Biosciences. Macroaxis does not own or have any residual interests in Calithera Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Calithera Biosciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Calithera BiosciencesBuy Calithera Biosciences
Not Rated
For the selected time horizon Calithera Biosciences has a Risk Adjusted Performance of 0.0949, Jensen Alpha of 14.62, Total Risk Alpha of (4.63), Sortino Ratio of 0.4508 and Treynor Ratio of (0.85)
We provide trade advice to complement the prevailing expert consensus on Calithera Biosciences. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Calithera Biosciences is not overpriced, please confirm all Calithera Biosciences fundamentals, including its gross profit, cash per share, and the relationship between the price to book and net income . As Calithera Biosciences appears to be a penny stock we also recommend to validate its price to book numbers.

Calithera Biosciences Trading Alerts and Improvement Suggestions

Calithera Biosciences is not yet fully synchronised with the market data
Calithera Biosciences has some characteristics of a very speculative penny stock
Calithera Biosciences has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (39.65 M) with loss before overhead, payroll, taxes, and interest of (42.7 M).
Calithera Biosciences currently holds about 41.79 M in cash with (43.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.59, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

Calithera Biosciences Returns Distribution Density

The distribution of Calithera Biosciences' historical returns is an attempt to chart the uncertainty of Calithera Biosciences' future price movements. The chart of the probability distribution of Calithera Biosciences daily returns describes the distribution of returns around its average expected value. We use Calithera Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Calithera Biosciences returns is essential to provide solid investment advice for Calithera Biosciences.
Mean Return
12.89
Value At Risk
-28.57
Potential Upside
16.67
Standard Deviation
52.50
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Calithera Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Calithera Biosciences Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Calithera . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Calithera Biosciences Buy or Sell Advice

When is the right time to buy or sell Calithera Biosciences? Buying financial instruments such as Calithera Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Calithera Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Trading Thematic Idea Now

Trading
Trading Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Trading theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Trading Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Calithera Pink Sheet

If you are still planning to invest in Calithera Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Calithera Biosciences' history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance